(Q39461463)

12 September 2017

1 reference

title

Which treatment for childhood acute lymphoblastic leukaemia in second remission? (English)

1 reference

12 September 2017

1 reference

A Butturini

1

1 reference

12 September 2017

G K Rivera

series ordinal

2

1 reference

12 September 2017

M M Bortin

series ordinal

3

1 reference

12 September 2017

R P Gale

series ordinal

4

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 February 1987

1 reference

12 September 2017

1 reference

12 September 2017

volume

1

1 reference

12 September 2017

issue

8530

1 reference

12 September 2017

page(s)

429-432

1 reference

Acute lymphoblastic leukemia in childhood.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Bone-marrow transplantation for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Recurrent childhood lymphocytic leukemia following cessation of therapy: treatment and response

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Recurrent childhood lymphocytic leukemia. Clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Poor outlook for childhood acute lymphoblastic leukaemia with relapse

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Combination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (all)

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Improved treatment results in the management of single and multiple relapses of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

[Treatment of relapse in acute lymphoblastic leukaemia of childhood (author's transl)].

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Combination chemotherapy for marrow relapse in children and adolescents with acute lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Relapse in childhood acute lymphoblastic leukemia after elective cessation of initial treatment: failure of subsequent treatment with cyclophosphamide, cytosine arabinoside, vincristine and prednisone (COAP).

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Intermittent combined chemotherapy with doxorubicin in recurrent childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Prolonged second remissions in childhood acute lymphocytic leukemia: a report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Outcome following late marrow relapse in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Randomized multicentric Italian study on two treatment regimens for marrow relapse in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Modified Capizzi maintenance regimen in children with relapsed acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Low-dose adriamycin remission maintenance for advanced acute lymphoblastic leukemia: a Southwest Oncology, Group study

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Favorable response to maintenance therapy of second or subsequent remissions in childhood acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Bone-marrow transplantation has a limited role in prolonging second marrow remission in childhood lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse, and graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Bone marrow transplantation for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Bone marrow transplantation for acute lymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.).

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Bone-Marrow Ablation and Allogeneic Marrow Transplantation in Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

Prediction and prevention of relapse of acute lymphoblastic leukaemia after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

How should acute lymphoblastic leukaemia relapsing after bone-marrow transplantation be treated?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(87)90128-0

7 January 2021

10.1016/S0140-6736(87)90128-0

Identifiers

DOI

1 reference

12 September 2017

1 reference